Author

Aubin Pitiot

Luxembourg Institute of HealthORCID 0000-0001-9453-019XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2

Frequent Co-Authors

Carole Seguin‐DevauxiD· 2 shared Gilles Iserentant· 2 shared Jacques ZimmeriD· 2 shared Jean-Yves Servais· 2 shared Anaïs OudiniD· 1 shared Anna GolebiewskaiD· 1 shared Bianca Brandus· 1 shared Camille RoliniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Carole Seguin‐DevauxORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintFeb 11, 2026

Strength in Unity: a Dual Strategy to Restore NK Cell Cytotoxicity against Pancreatic Ductal Adenocarcinoma

Camille Rolin, Aubin Pitiot, Gilles Iserentant…·Carole Seguin‐Devaux

This study develops and tests a dual strategy using NaMiX and TriKE to enhance NK cell cytotoxicity against PDAC, showing improved tumor cell killing in vitro and in humanized mouse models.

DOI 10.64898/2026.02.09.704789

humanexperimental assay

𝕏 PostBluesky

ImmunologyImmunoTargets and TherapyPeer-reviewedSep 1, 2025

Complement-Activating Multimeric Immunotherapeutic Complexes for HER2-breast cancer immunotherapy

Carole Seguin‐Devaux, Bianca Brandus, Jean‐Marc Plesséria…·Xavier Dervillez

This study develops and tests CoMiX immunotherapeutics that activate complement to kill HER2-positive breast cancer cells, showing significant tumor growth inhibition in xenograft models.

4 citations

humanexperimental assay

𝕏 PostBluesky